Terazosin
- Product NDC
- 71335-3059
- 11-digit product format
- 713353059
- Labeler code
- 71335
- Product ID
- 71335-3059_be7839c5-4321-43b7-8e9a-4f06cd8b9e99
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075667
- Marketing category
- ANDA
- Marketing start
- 2024-03-11
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 313217 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-3059-1 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
| 71335-3059-2 | Terazosin | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-3059-1 | 71335305901 | 30 CAPSULE in 1 BOTTLE (71335-3059-1) | 30 capsule | 2026-02-06 | No | No | Historical |
| 71335-3059-2 | 71335305902 | 90 CAPSULE in 1 BOTTLE (71335-3059-2) | 90 capsule | 2026-02-06 | No | No | Historical |